These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 714218

  • 1. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J, Lysakowska-Sernicka K, Gajewska A, Bilińska-Nigot B, Ostrowski K, Semenicki K.
    Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
    [Abstract] [Full Text] [Related]

  • 2. [Anginin effect in cerebovascular disorders in the light of psychological studies].
    Michalska I.
    Neurol Neurochir Pol; 1979; 13(2):141-6. PubMed ID: 377119
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W, Kruszewska J, Szymchel J.
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Late results of the pyridinolcarbamate treatment of thrombotic obliterating arterial diseases of the extremities].
    Fisanovich TI, Tolstova LG.
    Khirurgiia (Mosk); 1979 Sep; (9):76-80. PubMed ID: 502312
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Results obtained with prodectin in arteriosclerotic arterial obliteration of the lower extremities.
    Hunyi L.
    Ther Hung; 1976 Sep; 24(2):67-71. PubMed ID: 982342
    [No Abstract] [Full Text] [Related]

  • 10. Double-blind crossoer clinical trial of pyridinolcarbamate in peripheral arterial disease (arteriosclerosis obliterans).
    Walton KW, Craig GM, Prior P, Waterhouse JA, Skilton J.
    Br Heart J; 1973 Feb; 35(2):211-9. PubMed ID: 4570447
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of conservative (Prodectin) treatment and surgical intervention in arteriosclerotic obliterative diseases of the lower extremities.
    Hunyi L.
    Ther Hung; 1978 Feb; 26(2):77-80. PubMed ID: 684660
    [No Abstract] [Full Text] [Related]

  • 12. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV.
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN, Aleksandrova LM, Kliachko VR, Mazovetskiĭ AG.
    Ter Arkh; 1974 Jan; 46(1):107-10. PubMed ID: 4453966
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 20. [Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography].
    Motomiya T.
    Nihon Naika Gakkai Zasshi; 1970 Feb 10; 59(2):117-25. PubMed ID: 4910199
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.